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ABSTRACT
INTRODUCTION: Periodontitis and peri-implantitis are plaque-induced diseases, which are associated 
with certain bacteria. The conventional treatment aims primarily at tooth or implant surface debridement. 
In certain cases, surgical therapy is necessary. To improve the outcome of the treatment, systemic or topical 
antibiotics could be considered.
AIM: The aim of this review is to investigate the effect of the adjunctive systemically or topically delivered 
antibiotics on the outcome of the periodontitis and peri-implantitis treatment.
MATERIALS AND METHODS: Articles related to the topic were searched in the PubMed database. 
Articles published from 2000 to 2019, only in English language, were included in the review. The search was 
conducted with a variety of keywords in different combinations being used. These were: “periodontitis”, 
“peri-implantitis”, “antibiotic”, “local”, “metronidazole”, “amoxicillin”, “azithromycin”, “tetracycline”.
RESULTS: Forty-seven articles were included in the review. The selected articles described the adjunctive 
systemic and/or local delivery of metronidazole, azithromycin, the combination of metronidazole and 
amoxicillin and some representatives of the tetracycline group, such as doxycycline and minocycline in 
cases of periodontitis and peri-implantitis.
CONCLUSION: The adjunctive systemic and topical antibiotic therapy could benefit the outcome of 
periodontitis and peri-implantitis treatment.
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INTRODUCTION
Periodontitis and peri-implantitis are plaque-
induced diseases, which are associated with certain 
bacteria. The conventional treatment aims primarily 
at tooth or implant surface debridement. In certain 
cases, surgical therapy is necessary. To improve the 
outcome of the treatment, systemic or topical antibi-
otics could be considered.
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AIM
The aim of this review is to investigate the effect 
of the adjunctive systemically or topically delivered 
antibiotics on the outcome of the periodontitis and 
peri-implantitis treatment.
MATERIALS AND METHODS
Articles related to the topic were searched in 
the PubMed database. Articles published from 2000 
to 2019, only in English language, were included in 
the review. The search was conducted with a variety 
of keywords in different combinations being used. 
These were: “periodontitis”, “peri-implantitis”, “an-
tibiotic”, “local”, “metronidazole”, “amoxicillin”, 
“azithromycin”, “tetracycline”.
Metronidazole
Systemic metronidazole, in addition to the non-
surgical therapy of peri-implantitis, is an effective 
treatment in terms of radiographic parameters and 
probing depth (PD) (1). According to a study, bacteri-
al genes encoding for tetracycline resistance are typi-
cal for healthy sulci around implants and for cases of 
peri-implantitis. To a lesser extent, resistance to beta-
lactams is observed. The authors did not detect any 
resistance to metronidazole and support its use (2).
Lan et al. (3) introduced personalized poly-ε-
caprolactone/alginate rings loaded with metronida-
zole, whose purpose was to ensure controlled release 
of the agent. The authors concluded that this system 
has the potential to reduce the bacterial biofilm de-
velopment and thereby could be used for peri-im-
plantitis prevention.
Tang et al. (4) compared 25% metronidazole gel 
and ultrasonic scaling with carbon fiber tip and con-
cluded that both treatment modalities are reliable for 
peri-implantitis therapy.
The local application of metronidazole could 
lead to a destabilization of the supragingival biofilm 
(5). The combination of topically delivered metroni-
dazole and zinc hyaluronate has а comparable effect 
to that of amoxicillin on the oral pathogens (6). The 
topical delivery of 5% metronidazole along with the 
debridement could also have a positive effect on the 
periodontitis therapy (7).
Systemic administration of metronidazole 
combined with full-mouth disinfection is an efficient 
strategy in cases where P. gingivalis and T. forsythia 
are detected (8).
Amoxicillin + Metronidazole
The systemic administration of metronida-
zole and amoxicillin together is used in periodontitis 
(9,10,11,12,13) and in peri-implantitis treatment (14).
In vitro evaluation of the antibiotic resistance of 
the bacterial pathogens, typical for the submucosal 
microbiota in peri-implantitis patients demonstrated 
that these bacteria are frequently resistant to doxy-
cycline,  clindamycin, metronidazole and amoxicil-
lin. The authors also found that the bacteria are only 
infrequently resistant to both metronidazole and 
amoxicillin (15).
The combination of metronidazole and amoxi-
cillin, in addition to scaling and root planing (SRP), 
has led to improvement of the results of the peri-
odontal treatment of patients with type 2 diabetes 
mellitus (16).  El-Makaky and Shalaby (17) also stud-
ied the effect of periodontal therapy on the clinical 
parameters and metabolic response in patient with 
uncontrolled type 2 diabetes suffering from peri-
odontitis and concluded that the non-surgical thera-
py of periodontal disease combined with metronida-
zole and amoxicillin resulted in better metabolic out-
come and improved clinical parameters in regard to 
the periodontitis. The authors observed bleeding on 
probing (BOP), pocket depth, plaque, clinical attach-
ment level (CAL), and glycated hemoglobin. Oth-
er authors also came to a similar conclusion: the ad-
junctive amoxicillin and metronidazole administra-
tion increased the positive effects of the periodontal 
therapy, considering clinical parameters, such as PD, 
CAL and BOP (18).
McGowan et al. (19) recommended a 7-day 
course of metronidazole and amoxicillin. A study 
supported the regimen of 500 mg metronidazole 
and 500 mg amoxicillin, three times a day for 7 days 
in combination with SRP. The authors compared a 
3-day and a 7-day course and reported better results 
with the longer antibiotic course, considering im-
proved clinical parameters, decreased detection of 
some periopathogens and oxidative stress (20).
As an alternative of the combination of metro-
nidazole and amoxicillin, Araujo et al. (21) proposed 
clarithromycin, although the authors suggested that 
this antibiotic was not superior to the aforementioned 
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combination. Both antibiotic therapies led to reduced 
bacterial count of A. actinomycetemcomitans and P. 
gingivalis. The duration of both treatments was 7 
days with the dose of metronidazole and amoxicil-
lin being 400 mg three times a day and 500 mg three 
times a day, respectively. The dosage of clarithromy-
cin was 500 mg twice a day.
The systemic use of amoxicillin and metroni-
dazole in addition to surgical protocol for peri-im-
plantitis treatment  including also surgical access de-
bridement and decontamination of implant surface 
resulted in a positive effect, which was maintained 
for 12 months  (14).
During a peri-implantitis treatment, Stein et al. 
(22) administered amoxicillin and metronidazole for 
a period of 7 days to the patients with severe peri-
odontitis. Other authors did not observe any im-
provement of the results considering the clinical and 
microbiological parameters, adding metronidazole 
and amoxicillin to the non-surgical peri-implantitis 
treatment (23).
Tetracyclines
Local antimicrobial agents may improve the 
outcomes of periodontal surgical treatment and 
may reduce the peri-implantitis manifestations (24). 
Treatment of peri-implantitis by topical application 
of tetracyclines led to improvement of the microbio-
logical and clinical parameters (25).
Locally delivered tetracyclines are available in 
different forms, such as ointment (26), fibers (25, 27, 
28), and nanoparticles (29). Topical application of 
tetracycline is associated with significant positive 
effect on the clinical parameters, such as PD, sul-
cular bleeding index, and CAL (30). According to a 
study, the use of systemic and local antibiotics could 
decrease the inflammation at the surgical site after 
implant placement (31). Minocycline hydrochloride 
ointment and erythromycin eye ointment were ap-
plied locally at the implant surgery site. The effect 
on the healing was assessed and certain parameters 
were measured. The authors concluded that the ef-
fect of both ointments wаs comparable in regard to 
the early stage of the healing process (31). Local mi-
nocycline demonstrated considerable anti-inflam-
matory effects (29). The combination of tetracycline 
fibers and SRP is a reliable treatment, resulting in an 
improvement of the periodontal health (32).  Tetracy-
cline fibers combined with SRP are superior to SRP 
alone considering the clinical parameters, such as 
pocket depth and CAL (27).
Topical application of minocycline in combina-
tion with surgical treatment of peri-implantitis im-
proves the outcome of the therapy regarding the clin-
ical and radiological results (33). Radiographic and 
clinical parameters are also improved using nonsur-
gical treatment of peri-implantitis combined with ir-
rigation with chlorhexidine and local application of 
minocycline hydrochloride (34).
Topical application of controlled-release doxy-
cycline was included in an anti-infective non-surgi-
cal peri-implantitis treatment protocol, which dem-
onstrated improvement of peri-implant health, con-
sidering the clinical parameters (35). A new gel was 
proposed, which included metronidazole and dox-
ycycline in its formulation. The gel was efficient in 
vitro against planktonic species and against bacte-
rial biofilm. The effect continued 13 days. The au-
thors concluded that its use in cases of peri-implanti-
tis could be discussed (36). Nano-doxycycline gel in 
addition to SRP also demonstrated anti-inflammato-
ry effect (37).
According to a study, systemic doxycycline 
treatment did not influence A. actinomycetemcomi-
tans infection associated with peri-implantitis. The 
authors also concluded that periodontitis of the re-
maining teeth could contribute to the development 
of peri-implantitis (38). Residues of a minocycline 
hydrochloride agent could be found on the implant 
surface. Because it was hydrophobic it could not be 
removed well using water. 
Residual local agents on the implant surface in 
cases of peri-implantitis might compromise the re-
osseointegration and lead to bacterial colonization 
(39). In a study in dogs, it was reported that the appli-
cation of topical tetracycline hydrochloride solution 
was an effective method for decontamination of im-
plant surfaces, which were infected (40).
Azithromycin
Systemic delivery of azithromycin in combina-
tion with mechanical debridement could contribute 
to the management of peri-implant mucositis in the 
therapy of peri-implantitis (41). Some authors con-
cluded that the systemic administration of azithro-
mycin in addition to the surgical peri-implantitis 
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treatment was not superior to the surgical therapy 
alone (42). According to Tada et al. (43) the reduc-
tion of the bacterial number, caused by the system-
ic azithromycin, was followed by new increase there-
after. Gomi et al. (44) concluded that the increase of 
the periodontal bacteria was observed 6 months after 
the therapy, which included combination of azithro-
mycin and full-mouth SRP. According to O’Rourke 
(45), systemically delivered azithromycin could con-
tribute to the positive effect of the non-surgical peri-
odontal treatment, especially when the pocket depth 
was ≥ 6 mm. Yashima  et al. (46) reported compa-
rable results from full-mouth SRP, with and without 
systemic administration of azithromycin, consider-
ing the clinical parameters. Renatus et al. (47) sup-
ported the opinion about the positive effect of the 
systemic delivery of azithromycin during periodon-
titis treatment.
RESULTS
Forty-seven articles were included in the re-
view. The selected articles described the adjunc-
tive systemic and/or local delivery of metronidazole, 
azithromycin, the combination of metronidazole and 
amoxicillin, and some representatives of the tetracy-
cline group, such as doxycycline and minocycline in 
cases of periodontitis and peri-implantitis.
DISCUSSION
The majority of the studies supported the topi-
cal application of tetracyclines in adjunct to the peri-
odontitis and peri-implantitis treatment (24,25,27, 
29,30,32-35,37). One study reported debatable results 
because of the difficulty of removing completely one 
of the minocycline hydrochloride agents of the im-
plant surface (39).
Many authors observed positive effect of the 
systemic administration of the metronidazole and 
amoxicillin combination in adjunct to the periodon-
tal treatment in terms of the outcomes of the thera-
py (16-18,20).
Topical metronidazole was found efficient in 
cases of periodontitis and peri-implantitis (4-7).
The reports about the effect of systemically ad-
ministered azithromycin on the peri-implantitis and 
periodontitis treatment are debatable. According to 
some of the authors the adjunctive systemic deliv-
ery of azithromycin benefits the periodontitis (45) 
and peri-implantitis treatment (41), while according 
to others, the results of the treatment with and with-
out azithromycin administration were comparable 
(42,46).
CONCLUSION
The adjunctive systemic and topical antibiotic 
therapy could benefit the outcome of periodontitis 
and peri-implantitis treatment.
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